<?xml version="1.0" encoding="UTF-8"?>
<p id="p0065">In addition to those offered by regulators at the national or regional level, the WHO made available 2 global pathways for facilitating access to medical products in emergency situations: (1) the WHO Emergency Use and Listing, which aims to provide guidance to United Nations procurement agencies and regulators of WHO member states on the quality, tolerability, and performance of 
 <italic>inÂ vitro</italic> diagnostics
 <xref rid="bib14" ref-type="bibr">
  <sup>10</sup>
 </xref>; and (2) the WHO prequalification program, which aims to assess the quality, tolerability, and efficacy of medicinal products for priority diseases.
 <xref rid="bib4" ref-type="bibr">
  <sup>4</sup>
 </xref>
 <sup>,</sup>
 <xref rid="bib15" ref-type="bibr">
  <sup>15</sup>
 </xref>
</p>
